Maybe you thought we were done reporting on COVID and that we could collectively wash the memory of the most horrendous global social experiment ever devised down the drain.
You’d be wrong.
Now that we’re four years away from the beginning of the whole ordeal, the headlines that really matter are being written — and because the censors are currently distracted with silencing dissident opinions on war, Bidenomics, and immigration (among other things), we can actually read those headlines. (RELATED: Safe and Effective? The New York Times Revisits the COVID Jab.)
Today, the BBC reported that AstraZeneca is withdrawing its COVID jab, developed by scientists at the University of Oxford in just 10 months, from the market.
There are, as always, at least two ways to read this story. The way that AstraZeneca, Big Pharma, and Western governments would like us to read it is as follows: The more than 26 variants of COVID suggest that the virus is nimble enough to adapt to the vaccine. At this point, the AstraZeneca vax is simply outdated. It was an amazing scientific breakthrough, but it is no longer as effective as it once was. AstraZeneca is “incredibly proud” of its product, but it’s time to move on to brighter, better things.
If you’ve been following the AstraZeneca saga, you may notice that the story is missing a few relatively important details.
The timing of AstraZeneca’s announcement is curiously suspicious. Over the last few months, the company has spent a lot of time in the U.K.’s High Court defending against the allegations of some 50 individuals who suffered side effects after receiving the vaccine or whose family members died as a result of side effects of the vaccine. (RELATED: It’s Apparently ‘Racist’ to Protect Children From Parental Drug Use)
In February, AstraZeneca admitted that the vaccine could, “in very rare cases,” cause Thrombosis with Thrombocytopenia Syndrome (TTS) — a condition that causes blood clots and low blood platelet counts in patients and has been tied to at least 81 deaths in the U.K. in addition to “hundreds of serious injuries.”
Does the decision to pull the AstraZeneca vaccine from the market have anything to do with that case? Well, the company insists that it’s simply unfortunate timing. The vaccine, they tell us, was a wonderful thing. Three billion doses were administered, and, according to some independent estimates, some 6.5 million lives were saved in the vaccine’s first year.
Don’t worry. It’s all a coincidence, they say. Nothing to see here.
All the more reason to watch for these headlines.
This article is an excerpt from The American Spectator’s Spectator P.M. newsletter. Subscribe today to read future letters from our staff!
READ MORE:
